Skip to content

Effect of magnesium bisglycinate supplementation on sleep and fatigue parameters in healthy adults reporting poor sleep quality

Effect of magnesium bisglycinate supplementation on sleep and fatigue parameters in healthy adults reporting poor sleep quality - MaBiS

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00031494
Enrollment
140
Registered
2023-04-12
Start date
2023-04-20
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects with self-reported poor sleep

Interventions

Group 1: Daily intake of 2 capsules magnesium bisglycinate (250 mg magnesium and 1520mg glycine) Group 2: Daily intake of 2 placebo capsules (1770 mg cellulose)

Sponsors

Gottfried Wilhelm-Leibniz-Universität Hannover Institut für Lebensmittelwissenschaft und Humanernährung
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Self-reported bad sleep (RIS score >12); BMI between 18,5 and 35; Willingness to consume 2 capsules of the study product for 4 weeks.

Exclusion criteria

Exclusion criteria: Change in use of any medication and food ingredients affecting sleep and mood prior to intervention. Consumption of dietary supplements that contain magnesium (>200 mg/day) or glycine (1 g/day) <1 month prior to intervention. Severe chronic diseases (renal insufficiency, liver disease, concurrent cancer). No concurrent treatment for sleep disorder or depression. No major change in sleeping rhythm for professional (e.g., shift work) or private reasons. Chronic diseases of the gastrointestinal tract (ulcerative colitis, Crohn's disease, pancreatic insufficiency) and chronic diseases involving the immune system (i.e., Crohn’s disease, ulcerative colitis, rheumatoid arthritis, multiple sclerosis). Sleep apnea. Regular intake of laxatives. Pregnancy or breastfeeding. Alcohol, drug and/or medication dependence. Subjects not capable of giving consent. Refusal or withdrawal of consent by the subject. Concurrent participation in another clinical trial or participation within the past 30 days. Planned surgery within the next 3 months.

Design outcomes

Primary

MeasureTime frame
Sleep quality: Insomnia Severity Index (ISI) - Score

Secondary

MeasureTime frame
Sleep: Regensburg Insomnia Scale (RIS) Single-Item Sleep Quality Scale (SQS) 14 day sleep diary Stress: Perceived Stress Scale (PSS) Daytime Fatigue: Epworth Sleepiness Scale (ESS) Fatigue Severity Scale (FSS) Mood: Positive and Negative Affect Schedule (PANAS) Anxiety and Depression: Patient Health Questionnaire-4 (PHQ-4) Magnesium-rich diet: Classification by simplified consumption frequency

Countries

Germany

Contacts

Public ContactJulius Schuster

Gottfried Wilhelm-Leibniz-Universität Hannover Institut für Lebensmittelwissenschaft und Humanernährung

schuster@nutrition.uni-hannover.de0511 762 4927

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026